Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2026-01-29 @ 4:30 PM
Study NCT ID:
NCT01591161
Status:
COMPLETED
Last Update Posted:
2020-09-03
First Post:
2012-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Sponsor:
Bausch & Lomb Incorporated
Organization: